Market closed
Biora Therapeutics/BIOR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biora Therapeutics
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Ticker
BIOR
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
58
Website
BIOR Metrics
BasicAdvanced
$20M
Market cap
-
P/E ratio
-$3.56
EPS
1.25
Beta
-
Dividend rate
Price and volume
Market cap
$20M
Beta
1.25
52-week high
$2.71
52-week low
$0.47
Average daily volume
221K
Financial strength
Current ratio
0.2
Quick ratio
0.134
Long term debt to equity
-49.447
Total debt to equity
-54.459
Interest coverage (TTM)
-8.60%
Management effectiveness
Return on assets (TTM)
-125.06%
Return on equity (TTM)
82.60%
Valuation
Price to revenue (TTM)
16.79
Price to book
-0.22
Price to tangible book (TTM)
-0.21
Price to free cash flow (TTM)
-0.298
Growth
Revenue change (TTM)
777.55%
Earnings per share change (TTM)
-35.28%
3-year revenue growth (CAGR)
2.78%
3-year earnings per share growth (CAGR)
-67.83%
What the Analysts think about BIOR
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Biora Therapeutics stock.
BIOR Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BIOR Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
BIOR News
AllArticlesVideos
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewsWire·2 months ago
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
GlobeNewsWire·2 months ago
Biora Therapeutics Announces Funding Agreement with Existing Investors
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biora Therapeutics stock?
Biora Therapeutics (BIOR) has a market cap of $20M as of October 12, 2024.
What is the P/E ratio for Biora Therapeutics stock?
The price to earnings (P/E) ratio for Biora Therapeutics (BIOR) stock is 0 as of October 12, 2024.
Does Biora Therapeutics stock pay dividends?
No, Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders as of October 12, 2024.
When is the next Biora Therapeutics dividend payment date?
Biora Therapeutics (BIOR) stock does not pay dividends to its shareholders.
What is the beta indicator for Biora Therapeutics?
Biora Therapeutics (BIOR) has a beta rating of 1.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.